Gene and Cell Therapy Program AultCare offers an industry-leading solution, in its collaboration with Emerging Therapy Solutions (ETS), for managing the risk associated with the emergence and rapidly evolving space of gene and cell therapies. This service includes a defined Centers of Excellence network that focuses on specific therapies, plan document wording, and benefit design that drives the best outcomes and cost. AultCare collaborates with leading health systems with a history of participating in clinical trials to allow for an additional avenue for sourcing new and complex gene and cell therapies. This program supports to monitor thousands of clinical trials to determine what therapies will be coming to market and forecast exposures. The program also mitigates risk through access to expert panels of physicians and clinical guidelines that ensure members receive the appropriate treatments based on their sound criteria. Identification Process Prior Authorizations. Data mining from claims data. Predictive modeling of patient populations.
5
